Alentemol
From Wikipedia, the free encyclopedia
![]() |
|
Names | |
---|---|
IUPAC name
2-(Dipropylamino)-2,3-dihydro-1H-phenalen-5-ol
|
|
Identifiers | |
112891-97-1 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL2104081 |
ChemSpider | 54603 |
PubChem | 60574 |
|
|
|
|
Properties | |
C19H25NO | |
Molar mass | 283.42 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Alentemol (INN) (developmental code name U-66444B), or alentamol, is a selective dopamine autoreceptor agonist described as an antipsychotic, which was never marketed.[1][2]
References[edit]
- ^ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 143–. ISBN 978-0-8155-1856-3.
- ^ A.F. Casy (11 November 2013). The Steric Factor in Medicinal Chemistry: Dissymmetric Probes of Pharmacological Receptors. Springer Science & Business Media. pp. 178–. ISBN 978-1-4899-2397-4.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |